Case-based Management of Traumatic Brain Injury

You must log in to register

This wide-ranging course covers the significant breadth of the field of neurotrauma and critical care. It emphasizes practical as well as complex case management issues. Devices for ICP monitoring, parenchymal oxygen monitoring and cerebral blood flow monitoring are discussed.

Registration Fee

AANS Members	$99
Non-members	$149

CME Accreditation

The AANS designates this activity for a maximum of 6.25 AMA PRA Category 1 Credits™.

Learning Objectives

After completing this educational activity, participants should be able to:

Describe the ICU management of the TBI patient.
Describe the current surgical controversies in the management of the brain-injured patient.
Identify the current concepts in advanced neuromonitoring.

Faculty

Director(s):	Jack I. Jallo, MD, PhD, FAANS
Assistant Director:	Ryan S. Kitagawa, MD, FAANS
Faculty:	Gregory W.J. Hawryluk, MD, PhD, FAANS David O. Okonkwo, MD, PhD, FAANS Wellingson SIlva Paiva, MD (Brazil) Haejoe Park, MD Uzma Samadani, MD, PhD, FAANS Emily Sieg, MD Martina Stippler, MD, FAANS

This educational activity was recorded at the 2019 AANS Annual Scientific Meeting.

Disclosure Information

The AANS controls the content and production of this CME activity and attempts to ensure the presentation of balanced, objective information. In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclose any relationship they or their co-authors have with commercial interests, which may be related to the content of their lecture.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere or any other relationship to a commercial interest that provides sufficient reason for disclosure.

It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities. Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, it will be resolved prior to confirmation of the individual’s participation.

All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

Name	Organization	Relationship
David O. Okonkwo, MD, PhD, FAANS	Stryker, Zimmer Biomet, NuVasive	Consultant Fees, Other Financial Support
Uzma Samadani, MD, PhD, FAANS	Oculogica, Inc., Abbott Inc, Integra, National Football League, Medtronic	Stock Shareholder, Consultant Fees, Consultant Fees, Consultant Fees, Consultant FeesSpeaker's Bureau

Those who have reported they do not have any relationships with commercial interests:

Jack I. Jallo, MD, PhD, FAANS

Ryan S. Kitagawa, MD, FAANS

Gregory W.J. Hawryluk, MD, PhD, FAANS

Wellingson SIlva Paiva, MD (Brazil)

Haejoe Park, MD

Emily Sieg, MD

Martina Stippler, MD, FAANS

Disclaimer

The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care or course of management does not imply endorsement or disapproval of products.

Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients served.